FMRP appears to regulate glioblastoma stem-like cell proliferation through both canonical WNT/β-catenin and non-canonical WNT-ERK1/2 signaling pathways, influencing the stability of key transcription factors involved in glioma cell malignancy. This evidence concerns the gene FMR1 and central nervous system cancer.